Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neutrophils | 70 | 2024 | 3790 | 9.910 |
Why?
|
Microfluidic Analytical Techniques | 52 | 2021 | 825 | 7.440 |
Why?
|
Chemotaxis | 22 | 2023 | 601 | 5.660 |
Why?
|
Microfluidics | 35 | 2023 | 675 | 5.560 |
Why?
|
Chemotaxis, Leukocyte | 19 | 2023 | 660 | 4.060 |
Why?
|
Cell Movement | 38 | 2024 | 5223 | 3.620 |
Why?
|
Chemotactic Factors | 10 | 2024 | 197 | 2.920 |
Why?
|
Lab-On-A-Chip Devices | 7 | 2023 | 446 | 1.910 |
Why?
|
Candida albicans | 7 | 2024 | 376 | 1.810 |
Why?
|
Aspergillus fumigatus | 4 | 2024 | 158 | 1.750 |
Why?
|
Sepsis | 8 | 2023 | 2602 | 1.620 |
Why?
|
Burns | 10 | 2018 | 1887 | 1.470 |
Why?
|
Leukocytes | 8 | 2019 | 2030 | 1.350 |
Why?
|
Docosahexaenoic Acids | 7 | 2018 | 907 | 1.200 |
Why?
|
Spheroids, Cellular | 2 | 2021 | 332 | 1.190 |
Why?
|
Megakaryocytes | 2 | 2023 | 575 | 1.110 |
Why?
|
Aspergillosis | 3 | 2024 | 242 | 1.090 |
Why?
|
Microinjections | 2 | 2017 | 322 | 1.080 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 5 | 2018 | 221 | 1.030 |
Why?
|
Staphylococcus aureus | 4 | 2022 | 1461 | 0.910 |
Why?
|
Antifungal Agents | 3 | 2024 | 761 | 0.900 |
Why?
|
Blood | 3 | 2019 | 597 | 0.850 |
Why?
|
tau Proteins | 5 | 2021 | 2129 | 0.810 |
Why?
|
Complement C5a | 3 | 2021 | 100 | 0.800 |
Why?
|
Candidiasis | 5 | 2024 | 367 | 0.790 |
Why?
|
Hyphae | 3 | 2021 | 52 | 0.790 |
Why?
|
Nipecotic Acids | 1 | 2021 | 36 | 0.770 |
Why?
|
Complement Inactivating Agents | 1 | 2021 | 53 | 0.770 |
Why?
|
Interleukin-8 | 4 | 2018 | 705 | 0.750 |
Why?
|
Actinomyces | 1 | 2021 | 41 | 0.740 |
Why?
|
Antibiosis | 1 | 2021 | 46 | 0.730 |
Why?
|
Glutamine | 1 | 2023 | 578 | 0.720 |
Why?
|
Streptococcus | 1 | 2021 | 198 | 0.710 |
Why?
|
Neutrophil Infiltration | 3 | 2024 | 396 | 0.700 |
Why?
|
Host-Pathogen Interactions | 2 | 2020 | 1465 | 0.700 |
Why?
|
Leukocyte Disorders | 2 | 2022 | 12 | 0.700 |
Why?
|
Cell Separation | 9 | 2016 | 1726 | 0.700 |
Why?
|
Dimethyl Sulfoxide | 1 | 2021 | 252 | 0.680 |
Why?
|
Phagocytosis | 10 | 2024 | 1531 | 0.670 |
Why?
|
Blood Platelets | 3 | 2023 | 2485 | 0.670 |
Why?
|
Deoxyribonucleases | 2 | 2018 | 209 | 0.670 |
Why?
|
Complement Activation | 1 | 2021 | 448 | 0.670 |
Why?
|
Fungi | 2 | 2021 | 346 | 0.660 |
Why?
|
High-Throughput Screening Assays | 4 | 2018 | 940 | 0.660 |
Why?
|
Borrelia burgdorferi | 1 | 2021 | 183 | 0.650 |
Why?
|
Zebrafish | 5 | 2019 | 3038 | 0.640 |
Why?
|
Tissue Array Analysis | 2 | 2018 | 551 | 0.640 |
Why?
|
Models, Biological | 8 | 2020 | 9505 | 0.610 |
Why?
|
Cell Communication | 6 | 2020 | 1662 | 0.610 |
Why?
|
Colloids | 1 | 2018 | 127 | 0.600 |
Why?
|
Tretinoin | 1 | 2021 | 525 | 0.590 |
Why?
|
Inflammation | 17 | 2022 | 10865 | 0.580 |
Why?
|
Dictyostelium | 2 | 2017 | 70 | 0.550 |
Why?
|
Amyloid beta-Peptides | 6 | 2021 | 3891 | 0.540 |
Why?
|
Time-Lapse Imaging | 4 | 2020 | 195 | 0.540 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 14 | 0.540 |
Why?
|
Cell Migration Assays, Leukocyte | 1 | 2016 | 8 | 0.530 |
Why?
|
Alzheimer Disease | 10 | 2023 | 8721 | 0.530 |
Why?
|
Biofilms | 1 | 2021 | 634 | 0.520 |
Why?
|
Aniline Compounds | 1 | 2021 | 1094 | 0.520 |
Why?
|
Streptavidin | 1 | 2015 | 81 | 0.510 |
Why?
|
Biological Assay | 2 | 2018 | 629 | 0.510 |
Why?
|
Rats, Wistar | 5 | 2018 | 1891 | 0.500 |
Why?
|
HL-60 Cells | 6 | 2021 | 364 | 0.500 |
Why?
|
Cytoplasm | 1 | 2020 | 1503 | 0.490 |
Why?
|
Humans | 134 | 2024 | 768451 | 0.490 |
Why?
|
Lyme Disease | 1 | 2021 | 631 | 0.480 |
Why?
|
Biotin | 1 | 2015 | 256 | 0.470 |
Why?
|
Organoids | 2 | 2018 | 749 | 0.470 |
Why?
|
Dystonia Musculorum Deformans | 2 | 2014 | 158 | 0.460 |
Why?
|
Cells, Cultured | 17 | 2021 | 19041 | 0.460 |
Why?
|
Equipment Design | 12 | 2018 | 3530 | 0.440 |
Why?
|
Erythrocytes | 8 | 2023 | 2422 | 0.420 |
Why?
|
Models, Immunological | 1 | 2015 | 518 | 0.420 |
Why?
|
Microchemistry | 3 | 2008 | 55 | 0.410 |
Why?
|
Immune System | 1 | 2018 | 801 | 0.410 |
Why?
|
Capillaries | 1 | 2016 | 756 | 0.410 |
Why?
|
Cytoskeleton | 7 | 2019 | 1179 | 0.410 |
Why?
|
Cryopreservation | 4 | 2011 | 731 | 0.400 |
Why?
|
Immune System Diseases | 1 | 2014 | 255 | 0.400 |
Why?
|
Blood Chemical Analysis | 2 | 2016 | 436 | 0.390 |
Why?
|
Interleukin-1 | 1 | 2015 | 1251 | 0.380 |
Why?
|
Epithelial Cells | 3 | 2014 | 3697 | 0.380 |
Why?
|
Internationality | 1 | 2016 | 1007 | 0.360 |
Why?
|
Myosin Type II | 2 | 2021 | 70 | 0.350 |
Why?
|
Cell Migration Assays | 2 | 2012 | 22 | 0.350 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.350 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2014 | 757 | 0.340 |
Why?
|
Signal Transduction | 15 | 2024 | 23638 | 0.340 |
Why?
|
Brain | 6 | 2021 | 27438 | 0.340 |
Why?
|
Cell Line | 13 | 2023 | 15609 | 0.330 |
Why?
|
Single-Cell Analysis | 2 | 2018 | 2531 | 0.330 |
Why?
|
T-Lymphocytes | 4 | 2015 | 10273 | 0.330 |
Why?
|
Histones | 1 | 2020 | 2595 | 0.330 |
Why?
|
Immunity, Innate | 7 | 2023 | 3080 | 0.330 |
Why?
|
Cytokines | 8 | 2021 | 7449 | 0.330 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 699 | 0.320 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2024 | 895 | 0.320 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1034 | 0.320 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 489 | 0.320 |
Why?
|
Neurons | 7 | 2023 | 9504 | 0.310 |
Why?
|
Serum | 1 | 2009 | 208 | 0.310 |
Why?
|
Gene Expression Profiling | 7 | 2018 | 9507 | 0.310 |
Why?
|
Electronics | 1 | 2009 | 318 | 0.300 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2238 | 0.290 |
Why?
|
Neoplasms | 7 | 2023 | 22386 | 0.290 |
Why?
|
Ice | 3 | 2004 | 102 | 0.280 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1898 | 0.280 |
Why?
|
Lipoxins | 3 | 2015 | 419 | 0.280 |
Why?
|
Gene Expression | 3 | 2018 | 7605 | 0.280 |
Why?
|
Leukocyte Count | 2 | 2018 | 1604 | 0.280 |
Why?
|
Animals | 46 | 2022 | 169418 | 0.280 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2008 | 333 | 0.280 |
Why?
|
Larva | 3 | 2017 | 514 | 0.270 |
Why?
|
Rats | 8 | 2018 | 23839 | 0.270 |
Why?
|
Cell Line, Tumor | 16 | 2024 | 17149 | 0.270 |
Why?
|
Reactive Oxygen Species | 4 | 2024 | 2150 | 0.270 |
Why?
|
Microglia | 3 | 2019 | 1376 | 0.260 |
Why?
|
Blood Preservation | 2 | 2017 | 169 | 0.260 |
Why?
|
Cryoprotective Agents | 2 | 2021 | 128 | 0.260 |
Why?
|
Leukotriene B4 | 3 | 2021 | 281 | 0.250 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 2737 | 0.250 |
Why?
|
Micromanipulation | 1 | 2005 | 53 | 0.240 |
Why?
|
Exosomes | 1 | 2009 | 429 | 0.240 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2022 | 620 | 0.240 |
Why?
|
Eukaryotic Cells | 1 | 2006 | 192 | 0.240 |
Why?
|
Monocytes | 3 | 2022 | 2591 | 0.230 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 563 | 0.230 |
Why?
|
RNA | 5 | 2011 | 2727 | 0.230 |
Why?
|
Clinical Laboratory Techniques | 2 | 2011 | 749 | 0.230 |
Why?
|
Membranes, Artificial | 1 | 2006 | 367 | 0.230 |
Why?
|
Fibroblasts | 2 | 2014 | 4180 | 0.230 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2024 | 4362 | 0.220 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2024 | 257 | 0.220 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2518 | 0.220 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2024 | 175 | 0.220 |
Why?
|
Cells | 1 | 2004 | 166 | 0.220 |
Why?
|
Cell Size | 3 | 2018 | 626 | 0.210 |
Why?
|
Cell-Derived Microparticles | 2 | 2016 | 161 | 0.210 |
Why?
|
Skin | 5 | 2021 | 4520 | 0.210 |
Why?
|
Blood Cell Count | 3 | 2019 | 402 | 0.210 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2022 | 28 | 0.210 |
Why?
|
Candida | 2 | 2021 | 172 | 0.210 |
Why?
|
Microarray Analysis | 2 | 2020 | 752 | 0.200 |
Why?
|
Mitochondria | 2 | 2013 | 3672 | 0.200 |
Why?
|
Complement C3-C5 Convertases | 1 | 2021 | 30 | 0.200 |
Why?
|
Equipment and Supplies | 1 | 2004 | 273 | 0.200 |
Why?
|
Basidiomycota | 1 | 2021 | 17 | 0.200 |
Why?
|
Cell Aggregation | 3 | 2021 | 238 | 0.190 |
Why?
|
Plaque, Amyloid | 2 | 2018 | 769 | 0.190 |
Why?
|
P-Selectin | 3 | 2016 | 599 | 0.190 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.190 |
Why?
|
Cell Culture Techniques | 4 | 2018 | 1669 | 0.190 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 1412 | 0.190 |
Why?
|
Biological Phenomena | 1 | 2021 | 28 | 0.190 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2021 | 87 | 0.190 |
Why?
|
Necrosis | 2 | 2018 | 1621 | 0.190 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2017 | 958 | 0.180 |
Why?
|
Ascomycota | 1 | 2021 | 81 | 0.180 |
Why?
|
Cell Polarity | 4 | 2021 | 639 | 0.180 |
Why?
|
Complement C5 | 1 | 2021 | 104 | 0.180 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
Inflammation Mediators | 3 | 2016 | 1892 | 0.180 |
Why?
|
Nanotechnology | 3 | 2012 | 714 | 0.180 |
Why?
|
Nanostructures | 1 | 2006 | 553 | 0.180 |
Why?
|
Microtubules | 3 | 2013 | 1074 | 0.180 |
Why?
|
Tauopathies | 2 | 2018 | 328 | 0.180 |
Why?
|
Green Fluorescent Proteins | 6 | 2018 | 2072 | 0.180 |
Why?
|
Microtubule-Associated Proteins | 2 | 2018 | 1078 | 0.180 |
Why?
|
Cryoelectron Microscopy | 1 | 2004 | 652 | 0.170 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4622 | 0.170 |
Why?
|
Freezing | 4 | 2009 | 311 | 0.170 |
Why?
|
Stress, Mechanical | 2 | 2018 | 1680 | 0.170 |
Why?
|
Complement C3 | 1 | 2021 | 434 | 0.170 |
Why?
|
Organ Transplantation | 2 | 2021 | 1177 | 0.170 |
Why?
|
Time Factors | 16 | 2016 | 40271 | 0.170 |
Why?
|
Models, Theoretical | 6 | 2020 | 3590 | 0.160 |
Why?
|
Helicobacter pylori | 1 | 2022 | 382 | 0.160 |
Why?
|
Stochastic Processes | 2 | 2010 | 359 | 0.150 |
Why?
|
Biosensing Techniques | 1 | 2005 | 663 | 0.150 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 582 | 0.150 |
Why?
|
Coculture Techniques | 2 | 2021 | 1343 | 0.150 |
Why?
|
Adenine | 1 | 2024 | 993 | 0.150 |
Why?
|
Mouth | 1 | 2021 | 383 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 2 | 2020 | 2477 | 0.150 |
Why?
|
Mycoses | 1 | 2021 | 386 | 0.150 |
Why?
|
Immunity | 2 | 2021 | 1002 | 0.150 |
Why?
|
Leukocyte Elastase | 1 | 2018 | 115 | 0.150 |
Why?
|
Neural Stem Cells | 2 | 2018 | 892 | 0.150 |
Why?
|
Microtechnology | 1 | 2018 | 70 | 0.150 |
Why?
|
Phenotype | 4 | 2024 | 16712 | 0.150 |
Why?
|
Critical Illness | 3 | 2018 | 2754 | 0.140 |
Why?
|
Laboratory Animal Science | 1 | 2017 | 9 | 0.140 |
Why?
|
Chromatin | 2 | 2022 | 2969 | 0.140 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 631 | 0.140 |
Why?
|
Wound Healing | 4 | 2012 | 2819 | 0.140 |
Why?
|
Cell Tracking | 1 | 2018 | 140 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2422 | 0.140 |
Why?
|
Glutamate Decarboxylase | 1 | 2018 | 239 | 0.140 |
Why?
|
Carrier Proteins | 2 | 2023 | 4948 | 0.140 |
Why?
|
Molecular Chaperones | 2 | 2014 | 764 | 0.140 |
Why?
|
Peroxidase | 1 | 2020 | 610 | 0.140 |
Why?
|
Chemokine CXCL10 | 2 | 2015 | 311 | 0.140 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2018 | 370 | 0.140 |
Why?
|
Pseudomonas Infections | 1 | 2021 | 623 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 2 | 2021 | 1277 | 0.130 |
Why?
|
Anti-Inflammatory Agents | 3 | 2015 | 1816 | 0.130 |
Why?
|
Mice | 24 | 2022 | 82045 | 0.130 |
Why?
|
Ficoll | 1 | 2016 | 39 | 0.130 |
Why?
|
Young Adult | 11 | 2021 | 60045 | 0.130 |
Why?
|
Cell Survival | 5 | 2017 | 5801 | 0.130 |
Why?
|
Silicones | 1 | 2017 | 228 | 0.130 |
Why?
|
Succinimides | 1 | 2015 | 83 | 0.130 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2016 | 136 | 0.130 |
Why?
|
Cell Membrane Permeability | 1 | 2017 | 574 | 0.130 |
Why?
|
Cell Adhesion | 4 | 2014 | 3103 | 0.130 |
Why?
|
Piperidines | 1 | 2024 | 1664 | 0.120 |
Why?
|
Biophysical Phenomena | 2 | 2009 | 321 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 214 | 0.120 |
Why?
|
Median Eminence | 1 | 2014 | 28 | 0.120 |
Why?
|
Prostaglandins | 1 | 2015 | 398 | 0.120 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2015 | 222 | 0.120 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18388 | 0.120 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 586 | 0.120 |
Why?
|
Cromolyn Sodium | 1 | 2014 | 78 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2016 | 527 | 0.120 |
Why?
|
Leukotrienes | 1 | 2015 | 230 | 0.120 |
Why?
|
Confined Spaces | 1 | 2014 | 10 | 0.120 |
Why?
|
Chemokine CXCL12 | 2 | 2014 | 457 | 0.120 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7471 | 0.110 |
Why?
|
Cyclic N-Oxides | 1 | 2014 | 72 | 0.110 |
Why?
|
Cell Count | 2 | 2016 | 1835 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2018 | 1525 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2016 | 4419 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2022 | 1183 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2016 | 681 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2020 | 1162 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1855 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2020 | 1357 | 0.110 |
Why?
|
Microbial Sensitivity Tests | 2 | 2018 | 1965 | 0.110 |
Why?
|
Male | 28 | 2021 | 364781 | 0.110 |
Why?
|
Cell Nucleolus | 1 | 2014 | 156 | 0.110 |
Why?
|
rho GTP-Binding Proteins | 2 | 2013 | 279 | 0.110 |
Why?
|
Cell Differentiation | 4 | 2021 | 11674 | 0.110 |
Why?
|
Microvessels | 2 | 2015 | 586 | 0.110 |
Why?
|
Chemokines | 1 | 2018 | 963 | 0.110 |
Why?
|
Nerve Growth Factors | 1 | 2016 | 566 | 0.110 |
Why?
|
Adult | 16 | 2021 | 223542 | 0.110 |
Why?
|
Coloring Agents | 1 | 2016 | 564 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3351 | 0.110 |
Why?
|
Antigens | 2 | 2015 | 1443 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 1246 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1602 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8635 | 0.100 |
Why?
|
Pancreatic Elastase | 1 | 2012 | 126 | 0.100 |
Why?
|
Hydrodynamics | 1 | 2013 | 168 | 0.100 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2012 | 56 | 0.100 |
Why?
|
Golgi Apparatus | 1 | 2014 | 405 | 0.100 |
Why?
|
Dynamins | 1 | 2013 | 141 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 905 | 0.100 |
Why?
|
Microscopy, Phase-Contrast | 2 | 2009 | 110 | 0.100 |
Why?
|
Spin Labels | 1 | 2014 | 339 | 0.100 |
Why?
|
Laminin | 1 | 2014 | 407 | 0.100 |
Why?
|
Lymphocyte Count | 1 | 2014 | 793 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5709 | 0.100 |
Why?
|
Myosin Light Chains | 2 | 2022 | 122 | 0.100 |
Why?
|
Anisotropy | 1 | 2015 | 1296 | 0.100 |
Why?
|
Calibration | 2 | 2004 | 823 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1795 | 0.100 |
Why?
|
Microchip Analytical Procedures | 1 | 2011 | 29 | 0.100 |
Why?
|
Micro-Electrical-Mechanical Systems | 1 | 2011 | 30 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2016 | 22365 | 0.100 |
Why?
|
Point-of-Care Systems | 2 | 2011 | 1228 | 0.100 |
Why?
|
Biological Transport, Active | 1 | 2012 | 324 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2399 | 0.100 |
Why?
|
Cystic Fibrosis | 1 | 2021 | 1287 | 0.090 |
Why?
|
HIV Seropositivity | 2 | 2007 | 963 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2017 | 867 | 0.090 |
Why?
|
Equipment Failure Analysis | 2 | 2016 | 848 | 0.090 |
Why?
|
Mycobacterium smegmatis | 1 | 2011 | 126 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 9066 | 0.090 |
Why?
|
Temperature | 4 | 2009 | 2237 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 2 | 2007 | 2596 | 0.090 |
Why?
|
Mice, Transgenic | 7 | 2021 | 9558 | 0.090 |
Why?
|
Proteoglycans | 1 | 2014 | 807 | 0.090 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1173 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1950 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1095 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 607 | 0.090 |
Why?
|
Thrombosis | 2 | 2016 | 2956 | 0.090 |
Why?
|
Receptors, CXCR3 | 1 | 2011 | 240 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2611 | 0.090 |
Why?
|
Cell Migration Inhibition | 2 | 2008 | 97 | 0.090 |
Why?
|
Particle Size | 3 | 2008 | 1654 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2884 | 0.080 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 525 | 0.080 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2010 | 120 | 0.080 |
Why?
|
Eukaryota | 1 | 2010 | 101 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3472 | 0.080 |
Why?
|
Nocodazole | 1 | 2009 | 95 | 0.080 |
Why?
|
Kinetics | 4 | 2009 | 6348 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2889 | 0.080 |
Why?
|
Surface Properties | 2 | 2009 | 1168 | 0.080 |
Why?
|
Nucleic Acid Denaturation | 1 | 2009 | 110 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3212 | 0.080 |
Why?
|
Cell-Free System | 1 | 2009 | 340 | 0.080 |
Why?
|
Adolescent | 8 | 2021 | 89168 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2017 | 1703 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2016 | 1375 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2009 | 252 | 0.080 |
Why?
|
Macrophages | 3 | 2022 | 5797 | 0.080 |
Why?
|
Axonal Transport | 1 | 2009 | 178 | 0.080 |
Why?
|
Biomimetic Materials | 1 | 2010 | 173 | 0.080 |
Why?
|
Cell Membrane | 2 | 2016 | 3664 | 0.080 |
Why?
|
Bandages | 1 | 2010 | 273 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2021 | 26395 | 0.080 |
Why?
|
Ascitic Fluid | 1 | 2008 | 189 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1755 | 0.080 |
Why?
|
Exudates and Transudates | 1 | 2008 | 175 | 0.080 |
Why?
|
Female | 27 | 2024 | 396943 | 0.080 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 522 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2216 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2819 | 0.080 |
Why?
|
Antibodies | 1 | 2016 | 2425 | 0.080 |
Why?
|
Fractionation, Field Flow | 1 | 2007 | 3 | 0.080 |
Why?
|
Systems Biology | 1 | 2012 | 481 | 0.080 |
Why?
|
Ectoderm | 1 | 2008 | 138 | 0.070 |
Why?
|
Glycerol | 1 | 2009 | 275 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2018 | 1890 | 0.070 |
Why?
|
Motion | 2 | 2008 | 788 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2124 | 0.070 |
Why?
|
Silicon | 1 | 2008 | 143 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 163 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4417 | 0.070 |
Why?
|
Drug Approval | 1 | 2014 | 817 | 0.070 |
Why?
|
Nuclear Envelope | 1 | 2008 | 164 | 0.070 |
Why?
|
Drug Combinations | 1 | 2014 | 2079 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4213 | 0.070 |
Why?
|
Filtration | 1 | 2008 | 228 | 0.070 |
Why?
|
Connexin 43 | 1 | 2008 | 202 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 979 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2015 | 5495 | 0.070 |
Why?
|
Cell Extracts | 1 | 2007 | 135 | 0.070 |
Why?
|
Neoplasm Invasiveness | 2 | 2012 | 3637 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2819 | 0.070 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 267 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11930 | 0.070 |
Why?
|
Gap Junctions | 1 | 2008 | 230 | 0.070 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21156 | 0.070 |
Why?
|
DNA, Neoplasm | 2 | 2010 | 1749 | 0.070 |
Why?
|
Oocytes | 1 | 2011 | 1168 | 0.070 |
Why?
|
E-Selectin | 1 | 2008 | 578 | 0.070 |
Why?
|
Bioreactors | 1 | 2007 | 246 | 0.070 |
Why?
|
Actins | 3 | 2022 | 2064 | 0.070 |
Why?
|
Middle Aged | 11 | 2021 | 223418 | 0.070 |
Why?
|
Receptors, Interleukin-8B | 1 | 2005 | 58 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5808 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3713 | 0.060 |
Why?
|
Hemodynamics | 1 | 2016 | 4202 | 0.060 |
Why?
|
Mice, Nude | 1 | 2012 | 3635 | 0.060 |
Why?
|
Collagen | 1 | 2014 | 2646 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4630 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2007 | 450 | 0.060 |
Why?
|
Flow Cytometry | 6 | 2016 | 5904 | 0.060 |
Why?
|
Retroviridae | 1 | 2007 | 850 | 0.060 |
Why?
|
Embryonic Stem Cells | 2 | 2012 | 1249 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 2 | 2012 | 1671 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 725 | 0.060 |
Why?
|
Miniaturization | 1 | 2005 | 153 | 0.060 |
Why?
|
Membrane Proteins | 3 | 2010 | 7895 | 0.060 |
Why?
|
Child | 6 | 2022 | 80863 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 998 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2006 | 420 | 0.060 |
Why?
|
Oxygen | 1 | 2016 | 4269 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1625 | 0.060 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.050 |
Why?
|
Phosphorylation | 3 | 2021 | 8332 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2013 | 1746 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1136 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13708 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1814 | 0.050 |
Why?
|
Cholesterol | 1 | 2012 | 2910 | 0.050 |
Why?
|
Microspheres | 3 | 2013 | 789 | 0.050 |
Why?
|
GPI-Linked Proteins | 2 | 2017 | 473 | 0.050 |
Why?
|
Water | 1 | 2009 | 1421 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 561 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1129 | 0.050 |
Why?
|
Glycyrrhetinic Acid | 1 | 2002 | 15 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2020 | 4931 | 0.050 |
Why?
|
Leukocyte Transfusion | 1 | 2022 | 56 | 0.050 |
Why?
|
Microscopy, Fluorescence | 4 | 2013 | 2640 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20231 | 0.050 |
Why?
|
Kidney Transplantation | 2 | 2015 | 4285 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3586 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2004 | 1262 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3805 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2008 | 964 | 0.050 |
Why?
|
Aged | 7 | 2021 | 171520 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2014 | 5152 | 0.050 |
Why?
|
RNA Interference | 1 | 2010 | 2832 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5442 | 0.050 |
Why?
|
Candidemia | 1 | 2022 | 39 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2019 | 1563 | 0.050 |
Why?
|
Metabolomics | 1 | 2011 | 1675 | 0.050 |
Why?
|
Paclitaxel | 1 | 2009 | 1737 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6521 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4505 | 0.050 |
Why?
|
Pulmonary Aspergillosis | 1 | 2022 | 48 | 0.050 |
Why?
|
Chemokine CXCL2 | 1 | 2021 | 106 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22293 | 0.050 |
Why?
|
Neuroimmunomodulation | 1 | 2023 | 188 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 277 | 0.050 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2021 | 188 | 0.050 |
Why?
|
Markov Chains | 1 | 2004 | 977 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 379 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1348 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2011 | 1931 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 237 | 0.040 |
Why?
|
Antibodies, Neutralizing | 2 | 2021 | 2008 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 134 | 0.040 |
Why?
|
HIV | 1 | 2007 | 1596 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7064 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14158 | 0.040 |
Why?
|
Mutation | 4 | 2013 | 30243 | 0.040 |
Why?
|
Cell Surface Extensions | 1 | 2019 | 66 | 0.040 |
Why?
|
Transplants | 1 | 2021 | 208 | 0.040 |
Why?
|
Cytoskeletal Proteins | 2 | 2019 | 1337 | 0.040 |
Why?
|
Cryosurgery | 1 | 2004 | 477 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3939 | 0.040 |
Why?
|
Cell Adhesion Molecules | 2 | 2017 | 1615 | 0.040 |
Why?
|
Neuroglia | 1 | 2023 | 961 | 0.040 |
Why?
|
Myosins | 1 | 2019 | 409 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3108 | 0.040 |
Why?
|
Actin-Related Protein 2 | 1 | 2017 | 40 | 0.040 |
Why?
|
Actin-Related Protein 3 | 1 | 2017 | 48 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 990 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 529 | 0.030 |
Why?
|
Perfusion | 1 | 2022 | 1402 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14728 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3794 | 0.030 |
Why?
|
Proteomics | 1 | 2010 | 3901 | 0.030 |
Why?
|
Microscopy | 2 | 2014 | 909 | 0.030 |
Why?
|
Eosinophils | 1 | 2021 | 955 | 0.030 |
Why?
|
Optics and Photonics | 2 | 2008 | 307 | 0.030 |
Why?
|
Hepatocytes | 2 | 2017 | 1247 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2014 | 1674 | 0.030 |
Why?
|
Neurofibrillary Tangles | 1 | 2018 | 458 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54914 | 0.030 |
Why?
|
Specimen Handling | 2 | 2011 | 709 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2015 | 59680 | 0.030 |
Why?
|
Computer Simulation | 2 | 2008 | 6278 | 0.030 |
Why?
|
Flavonols | 1 | 2014 | 85 | 0.030 |
Why?
|
Genomics | 1 | 2010 | 5909 | 0.030 |
Why?
|
Models, Molecular | 1 | 2004 | 5443 | 0.030 |
Why?
|
Presenilin-1 | 1 | 2018 | 669 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4572 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4029 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3342 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1254 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2024 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2393 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 699 | 0.030 |
Why?
|
Osmosis | 1 | 2012 | 103 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2018 | 1115 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1019 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15965 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2415 | 0.030 |
Why?
|
Thienamycins | 1 | 2011 | 29 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 796 | 0.020 |
Why?
|
Platelet Activating Factor | 1 | 2012 | 143 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3050 | 0.020 |
Why?
|
Swine | 1 | 2022 | 5996 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 903 | 0.020 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2011 | 49 | 0.020 |
Why?
|
Flavonoids | 1 | 2014 | 447 | 0.020 |
Why?
|
Receptors, CCR4 | 1 | 2011 | 77 | 0.020 |
Why?
|
Cycloserine | 1 | 2011 | 118 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12774 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2633 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 2011 | 154 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3399 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2013 | 302 | 0.020 |
Why?
|
L-Selectin | 1 | 2011 | 212 | 0.020 |
Why?
|
Tubulin | 1 | 2014 | 695 | 0.020 |
Why?
|
Oxidants | 1 | 2011 | 169 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8753 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2011 | 277 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4138 | 0.020 |
Why?
|
Protective Agents | 1 | 2011 | 151 | 0.020 |
Why?
|
Biotinylation | 1 | 2010 | 185 | 0.020 |
Why?
|
Isoniazid | 1 | 2011 | 288 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6135 | 0.020 |
Why?
|
Formamides | 1 | 2009 | 21 | 0.020 |
Why?
|
Models, Statistical | 1 | 2004 | 5103 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16029 | 0.020 |
Why?
|
Rifampin | 1 | 2011 | 345 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5426 | 0.020 |
Why?
|
Dependovirus | 1 | 2014 | 720 | 0.020 |
Why?
|
Blood Cells | 1 | 2011 | 308 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 662 | 0.020 |
Why?
|
Diffusion Chambers, Culture | 1 | 2008 | 49 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2010 | 286 | 0.020 |
Why?
|
Plectin | 1 | 2008 | 14 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1755 | 0.020 |
Why?
|
Emulsions | 1 | 2009 | 152 | 0.020 |
Why?
|
Adhesiveness | 1 | 2008 | 52 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5042 | 0.020 |
Why?
|
Cell Wall | 1 | 2011 | 420 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1339 | 0.020 |
Why?
|
Amides | 1 | 2011 | 452 | 0.020 |
Why?
|
Polystyrenes | 1 | 2008 | 105 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2011 | 10494 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36497 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10784 | 0.020 |
Why?
|
Crystallization | 1 | 2009 | 531 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.020 |
Why?
|
Vimentin | 1 | 2008 | 257 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42623 | 0.020 |
Why?
|
Fermentation | 1 | 2008 | 142 | 0.020 |
Why?
|
Dimethylpolysiloxanes | 1 | 2008 | 143 | 0.020 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 179 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2958 | 0.020 |
Why?
|
Rheology | 1 | 2008 | 349 | 0.020 |
Why?
|
Mesoderm | 1 | 2010 | 679 | 0.020 |
Why?
|
Integrins | 1 | 2012 | 845 | 0.020 |
Why?
|
Hemorheology | 1 | 2007 | 144 | 0.020 |
Why?
|
Thermodynamics | 1 | 2009 | 594 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2009 | 781 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8908 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2010 | 13589 | 0.020 |
Why?
|
Monitoring, Immunologic | 1 | 2007 | 100 | 0.020 |
Why?
|
Urea | 1 | 2009 | 447 | 0.020 |
Why?
|
Viscosity | 1 | 2007 | 336 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2014 | 825 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1021 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 611 | 0.020 |
Why?
|
Peritonitis | 1 | 2008 | 368 | 0.020 |
Why?
|
Cell Shape | 1 | 2007 | 371 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2008 | 286 | 0.020 |
Why?
|
Coated Materials, Biocompatible | 1 | 2008 | 311 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1669 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4294 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 1770 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3546 | 0.020 |
Why?
|
DNA | 2 | 2010 | 7213 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 2005 | 176 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 669 | 0.020 |
Why?
|
Rotation | 1 | 2007 | 517 | 0.020 |
Why?
|
Th1 Cells | 1 | 2011 | 1044 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2006 | 359 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2014 | 81834 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 525 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10601 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3783 | 0.020 |
Why?
|
Th2 Cells | 1 | 2011 | 1079 | 0.020 |
Why?
|
Pseudopodia | 1 | 2005 | 168 | 0.020 |
Why?
|
Huntington Disease | 1 | 2012 | 1145 | 0.020 |
Why?
|
Response Elements | 1 | 2006 | 308 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2944 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4479 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3890 | 0.010 |
Why?
|
Genotype | 2 | 2009 | 13047 | 0.010 |
Why?
|
Ovalbumin | 1 | 2006 | 678 | 0.010 |
Why?
|
Sirolimus | 1 | 2011 | 1542 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4586 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2006 | 490 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18478 | 0.010 |
Why?
|
Protein Transport | 1 | 2009 | 1963 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2942 | 0.010 |
Why?
|
Embryonic Development | 1 | 2008 | 722 | 0.010 |
Why?
|
Proteome | 1 | 2013 | 1881 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2011 | 3169 | 0.010 |
Why?
|
Electric Impedance | 1 | 2007 | 796 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1614 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 828 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1977 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1355 | 0.010 |
Why?
|
HeLa Cells | 1 | 2008 | 3090 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2604 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9263 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2005 | 1468 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3790 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5767 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 2008 | 813 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2006 | 729 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2005 | 1207 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26351 | 0.010 |
Why?
|
United States | 2 | 2022 | 73121 | 0.010 |
Why?
|
HIV Antibodies | 1 | 2007 | 1341 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9382 | 0.010 |
Why?
|
HIV Infections | 1 | 2006 | 17564 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4120 | 0.010 |
Why?
|
Virus Replication | 1 | 2007 | 2459 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12428 | 0.010 |
Why?
|
Escherichia coli | 1 | 2011 | 4220 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2008 | 1398 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3805 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2575 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1797 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2279 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1044 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41797 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9526 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6537 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12813 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2006 | 2568 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 2006 | 1505 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 8201 | 0.010 |
Why?
|
Glioma | 1 | 2009 | 3523 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12561 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2009 | 5827 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14480 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13655 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9623 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 30179 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 30028 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2015 | 65409 | 0.000 |
Why?
|
Hospitalization | 1 | 2008 | 10845 | 0.000 |
Why?
|
Risk Factors | 1 | 2015 | 74915 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11206 | 0.000 |
Why?
|
Transcription Factors | 1 | 2006 | 12174 | 0.000 |
Why?
|